Diane Marie Nadeau, RN CDOE | |
2 Maxson Hill Rd, Ashaway, RI 02804 | |
(401) 287-1153 | |
Not Available |
Full Name | Diane Marie Nadeau |
---|---|
Gender | Female |
Speciality | Registered Nurse |
Location | 2 Maxson Hill Rd, Ashaway, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1407581499 | NPI | - | NPPES |
20280 | Other | RI | RN LICENSE |
177864 | Other | CT | RN LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163W00000X | Registered Nurse | 20280 (Rhode Island) | Secondary |
163W00000X | Registered Nurse | 177864 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Diane Marie Nadeau, RN CDOE 2 Maxson Hill Rd, Ashaway, RI 02804 Ph: (401) 287-1153 | Diane Marie Nadeau, RN CDOE 2 Maxson Hill Rd, Ashaway, RI 02804 Ph: (401) 287-1153 |
News Archive
The rapid growth of cell-based immunotherapy research has led to an increase in demand for methods to isolate specific immune cell populations from heterogeneous samples with high viability, purity and recovery efficiency. Quad Technologies ("Quad"), is meeting this need with its MagCloudz™ Streptavidin Cell Separation Kits and has partnered with The University of Massachusetts Medical School to evaluate the performance of its novel cell separation solution for the enrichment and purification of CD3+ T-cells from human umbilical cord blood.
Data presented at the 28th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize transplant patient care.
Children of older mothers experience fewer behavioral, social and emotional problems, according to a new study.
QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.
› Verified 7 days ago